➕ More is not always better: Finding the sweet spot by avidity tuning of CARs => https://t.co/vp6EHrygwI https://t.co/B5xqoLzNRY
2,862 followers
168 followers
RRIDs were included in the Frontiers in Immunology paper "Engineering of an Avidity-Optimized CD19-Specific…" (https://t.co/TBm2CRH10n). Thank you for making your #methodsmatter. #RRID
111 followers
RT @Leucidbio: @Leucidbio's pCAR platform delivers enhanced anti-tumor activity through effective provision of dual co-stimulation #CARTcel…
111 followers
@Leucidbio's pCAR platform delivers enhanced anti-tumor activity through effective provision of dual co-stimulation #CARTcell #CD19 #lymphoma https://t.co/abHhrU3y7Q